This study represents a pioneering systematic review comparing short-term and long-term effects of anti-CTLA-4 and anti-PD-1 therapies in CRC, acknowledging certain limitations and the need for ongoing investigation to refine and validate these findings. Here, CTLA4 is linked to colorectal carcinoma.